Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Smoking Cessation Trial on Adaptive Pharmacotherapy

NCT02501265 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02501265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02501265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Smoking Cessation Trial on Adaptive Pharmacotherapy
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
June 6, 2017
Completion date
May 12, 2021
Enrollment
188 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence